Bedzra Edo, Don Creighton W, Reisman Mark, Aldea Gabriel S
Division of Cardiothoracic Surgery, University of Washington Medical Center, Seattle, Washington.
Division of Cardiology, University of Washington Medical Center, Seattle, Washington.
Ann Thorac Surg. 2016 Aug;102(2):e97-9. doi: 10.1016/j.athoracsur.2015.12.042.
A 71-year-old man presented with New York Heart Association (NYHA) class IV heart failure. He had undergone transapical mitral valve replacement for mixed mitral stenosis and mitral regurgitation. At the 1 month follow-up, the patient reported symptom resolution. An echocardiogram revealed a low gradient and no regurgitation. Our case shows that with careful multidisciplinary evaluation, preoperative planning, and patient selection, percutaneous mitral intervention can become an alternative therapy for high-risk patients who cannot undergo conventional surgical therapy.
一名71岁男性患者出现纽约心脏协会(NYHA)IV级心力衰竭。他因二尖瓣狭窄合并二尖瓣反流接受了经心尖二尖瓣置换术。在1个月的随访中,患者报告症状缓解。超声心动图显示压差低且无反流。我们的病例表明,通过仔细的多学科评估、术前规划和患者选择,经皮二尖瓣介入治疗可以成为无法接受传统手术治疗的高危患者的替代治疗方法。